Z-VAD-FMK

Catalog No.S7023

Z-VAD-FMK Chemical Structure

Molecular Weight(MW): 467.49

Z-VAD-FMK is a cell-permeable, irreversible pan-caspase inhibitor, blocks all features of apoptosis in THP.1 and Jurkat T-cells.

Size Price Stock Quantity  
USD 117 In stock
USD 470 In stock

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

3 Customer Reviews

  • (A and B) Western blot analysis examining the effect of zVAD-fmk on the icaritin-induced apoptosis. The caspase inhibitor zVAD-fmk could significantly decrease the icaritin-induced cleaved caspase-3 expression. β-Actin protein levels indicate that an equal amount of protein was loaded into each lane.n=3. Mean±SD. bP<0.05, compared to the control group. eP<0.05, compared to the icaritin-treated group.

    Acta Pharmacol Sin 2014 35(4):531-9. Z-VAD-FMK purchased from Selleck.

    Active caspase-3 expression analysis. SW1116 cells were treated with ZBH-1205, CPT-11 and SN38 at 25 μmol/L for 48 h, in the presence or absence of Z-VAD-FMK (50 μmol/L, 1 h ahead of time). *P= 0.0345. Z-VAD-FMK(-) vs. Z-VAD-FMK(+). E: Cell cycle analysis. F: Apoptosis analysis. #P=0.0259. Z-VAD-FMK(-) vs. Z-VAD-FMK(+). ALL experiments were repeated three times.

    Arch Biochem Biophys, 2016, 604:74-85.. Z-VAD-FMK purchased from Selleck.

  • Effect on the RAS of CFZ, z-VAD-fmk, or CFZ + z-VAD-fmk treatments administered 5 or 12 days after C26 inoculation and control groups. Western blot analysis of ATF2 and pATF2. CP, ZP and UP were treated for 5 days; CT, ZT, UT and CC were treated for 12 days. CFZ (CP), z-VAD-fmk (ZP), CFZ + z-VAD-fmk (UP), PBS only (CC), healthy control (HC).

    Med Oncol, 2015, 32(4): 538 . Z-VAD-FMK purchased from Selleck.

Purity & Quality Control

Choose Selective Caspase Inhibitors

Click to view more

Notes:

2. For more details, such as half maximal inhibitory concentrations (IC50s) and working concentrations of each inhibitor, please click on the link of the inhibitor of interest.
3. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation.
4. Orange "√" refers to compounds which do inhibitory effects on the related isoform, but without specific value.

Biological Activity

Description Z-VAD-FMK is a cell-permeable, irreversible pan-caspase inhibitor, blocks all features of apoptosis in THP.1 and Jurkat T-cells.
Features A key compound for apoptosis studies.
Targets
Pan-caspase [1]
(THP.1, Jurkat T-cells)
In vitro

Z-VAD-FMK (10 mM) inhibits apoptosis in THP.1 cells. Z-VAD-FMK (10 μM) inhibits activation of PARP protease activity in control THP.1 cell lysates. Z-VAD-FMK (10 mM) inhibits the processing of CPP32 in intact THP.1 and Jurkat cells. [1] Z-VAD-FMK (50 μM) cotreatment abolishes the apoptotic morphology of camptothecin-treated HL60 cells. Z-VAD-FMK (50 μM) blocks camptothecin-induced DNA fragmentation in HL60 cells. [2] Z-VAD-FMK (50 μM) inhibits cell death following dSMN dsRNA-induced apoptosis in S2 cells. Z-VAD-FMK (50 μM) increases the percentage of transfected cells surviving from 26% to 63% in S2 cells. [3] Z-VAD-FMK (> 100 μM) enhances TNFα-induced neutrophil apoptosis, lower concentrations (1-30 μM) completely blocks TNFα-stimulated apoptosis in human neutrophils. [4] Z-VAD-FMK (10 mM) inhibits apoptosis in anterior stromal keratocytes. Z-VAD-FMK (10 mM) inhibits apoptosis in anterior stromal keratocytes detected with the TUNEL assay. [5]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
GC1a M4PRRmFxd3C2b4Ppd{BCe3OjeR?= NHj0XXQ2OM7:TR?= MUmyOIg> MoDhbY5lcWOjdHXzJIEheHKxdHXjeIl3\SCnZn\lZ5Qh[WejaX7zeEBmfG:yb4Pp[IU> MljGNlYyPjlyN{W=
HGL5 NFfRcW9CeG:ydH;zbZMhSXO|YYm= MUG1NO69VQ>? M2rtclI1cA>? M2jpd4lv\GmlYYTld{BiKHC{b4TlZ5RqfmViZX\m[YN1KGGpYXnud5Qh\XSxcH;zbYRm NG\tZYgzPjF4OUC3OS=>
HepG2 M4rZUmFxd3C2b4Ppd{BCe3OjeR?= MkC3NlDPxE1? M1PDb|Fp MmjoZZR1\W63YYTl[EB1cGViYYDvdJRwfGmlIHnu[JVkfGmxbjDv[kBKUUlvMUFCpC=> M4fxSlI3OTZ2N{m1
BEL-7402 M{PqcGFxd3C2b4Ppd{BCe3OjeR?= NFztPYszOM7:TR?= M3vhbFFp M3[3R4F1fGWwdXH0[YQhfGinIHHwc5B1d3SrYzDpcoR2[3Srb36gc4YhUUmLLUGwxsA> NFi4R5YzPjF4NEe5OS=>
CEF NHq4ZlVMcW6jc3WgRZN{[Xl? NXTIdnBWOCx|Mzy2O{wyODEQvF2= NWOweGJMOTWvaX6= NV7nSVNy\G:5bj3y[Yd2dGG2ZYOgVHIh\W68eX3lJIFkfGm4aYT5JJRwKDRy78{FJIF1KDFyMN88US=> M1XkdFI3OTB{M{O5
SP2/0 NGXFWY5CeG:ydH;zbZMhSXO|YYm= MmfnNVAx|ryP MoTINYg> M1mwTWROW09? MmXQZoxw[2u|IITo[UBieG:ydH;zbZMhd2ZiU2CyM|Ah[2WubIO= NGXhW|EzPjB5NEezNi=>
HUVEC-2c MkDSRZBweHSxc3nzJGF{e2G7 NIK1SII2OM7:TR?= M4jhfVZp NVrZSVli\GWlcnXhd4VlKHSqZTDvfE1NTExvaX7keYNm\CCjdYTvdIhi\3l? NHLqSW8zPjB{MUeyPS=>
U1 MXfBdI9xfG:|aYOgRZN{[Xl? M1u2[VAuOTByzszN M3\lb|Jp M1zvepJm\HWlZYOg[JJ2\y2rbnT1Z4VlKGGyb4D0c5NqeyCjbnSgd5Vje2WzdXXueEBJUVZvMTDy[ZBtcWOjdHnvckBqdiCjIHTvd4Uu\GWyZX7k[Y51KG2jbn7ldi=> NXGwT5c5OjV7OEC5OFI>
ACH-2 NUW5NXBbSXCxcITvd4l{KEG|c3H5 MYmwMVIxOM7:TR?= MUmybC=> MUTy[YR2[2W|IHTyeYcucW6mdXPl[EBieG:ydH;zbZMh[W6mIIP1ZpNmeXWnboSgTGlXNTFicnXwcIlk[XSrb36gbY4h[SCmb4PlMYRmeGWwZHXueEBu[W6wZYK= MYWyOVk5ODl2Mh?=
U1 M{Hr[WtqdmG|ZTDBd5NigQ>? M1nNbFExOM7:TR?= M3vpPVJp NI[xOYxqdmirYnn0d{Bk[XOyYYPlMVM> NHS4fnczPTl6MEm0Ni=>
A549/V16 M4frRmFxd3C2b4Ppd{BCe3OjeR?= NFfmeWw2OM7:TR?= MXKxbC=> NH70TGRz\XC{ZYPz[ZMhXEdxVF2tbY5lfWOnZDDhdI9xfG:|aYO= MkG4NlU6PDZyM{O=
SGN MYfBdI9xfG:|aYOgRZN{[Xl? MnK4NlBuVQ>? MXG0PIg> NGrOZphp[XNibn:gbY5ndHWnbnPlJI9vKEGLRjygZ4FteGGrbjDlfJBz\XO|aX;uJI9zKGOnbHygZZBweHSxc3nz NUDPOXZCOjV6N{S2N|M>
HCT116  M4C3UGFxd3C2b4Ppd{BCe3OjeR?= M3m1ZlUx|ryP MlHxNog> M4f4OYlvcGmkaYTzJJRp\SClZXzsJIRm[XSqIHnu[JVk\WRiYomgSGRXWA>? NETwdZAzPTh4OEixPC=>
DTK-SME MWfBdI9xfG:|aYOgRZN{[Xl? NHrKcHc2OM7:TR?= NVjEWpRvOmh? M{XXSWROW09? M3nzdZBienSrYXzsfUBqdmirYnn0d{B1cGViYYDvdJRwe2m|IHnu[JVk\WRiYomgZpVxcX[jY3HpcoU> NG[yemMzPTh2M{i5Oy=>
HL-60 MlzyRZBweHSxc3nzJGF{e2G7 NHXtfZg2OM7:TR?= MXm0PIg> MVLy[YR2[2W|IHPlcIwh\GWjdHigZ4F2e2WmIHL5JHNMUS2LSTD0doVifG2nboVCpC=> MmDRNlU5OjRyNEO=
U937 M3\MdmFxd3C2b4Ppd{BCe3OjeR?= MoLGOVDPxE1? MWK0PIg> MWHy[YR2[2W|IHPlcIwh\GWjdHigZ4F2e2WmIHL5JHNMUS2LSTD0doVifG2nboVCpC=> NXmwfI1rOjV6MkSwOFM>
A549 MYjBdI9xfG:|aYOgRZN{[Xl? NGfJWJgzOCEQvF2= MWeyOIg> NVXOT4s3emWmdXPld{Bk\WyuIHTlZZRpKGOjdYPl[EBjgSCKRlPQJJRz\WG2bXXueC=> NV\SeGxxOjV5OUSxOFk>
HeLa NXftU2FNSXCxcITvd4l{KEG|c3H5 NYLzSVZ[OTEQvF2= M{\Yb|Q5cA>? NYLnfI1O\GWlbHnu[ZMhfGinIILheIUhd2ZiYYDvdJRwe2m|IHTyZY1ifGmlYXzsfS=> NFrHXFAzPTd5MkW0OS=>
SGC-7901 M3TQcGFxd3C2b4Ppd{BCe3OjeR?= NFe4UVczOMLizszN MVyxbC=> MX;pcohq[mm2czD0bIUh[2WubDDk[YF1cCCrbnT1Z4VlKGK7IH;4ZYxqeGyjdHnu NEXjUZozPTd4N{C3Oi=>
MCF-7 NEPXN3dCeG:ydH;zbZMhSXO|YYm= MVexNO69VQ>? MX6ybC=> NEnTfIFqdmirYnn0d{B1cGViY3XscEBl\WG2aDDpcoR2[2WmIHL5JFND MVGyOVczOjFzNB?=
A549 M3XXPWFxd3C2b4Ppd{BCe3OjeR?= MWOxNEDPxE1? M{fI[FI1cA>? NYHKOIp5TE2VTx?= NEf0[ZZxem:vb4Tld{BJSkNvdILlZZRm\CCDNUS5JINmdGxic4Xyeol3[WxiJjDheJRmdnWjdHXzJJRp\SClbHXheoVlKFCDUmCg[ZhxemW|c3nvci=> MX6yOVY5OzV4OB?=
U87 NY\TUGpDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3j2XVUx|ryP NY\GV|JFOWh? NYn0W3F1emWlb4\ldpMh[2WubDDndo94fGhiZoLvcUBVVVpidILlZZRu\W62 NIDxNYczPTZ6MU[2PC=>
Neocortical Neuron M4jVU25mfXKxdH;4bYNqfHliQYPzZZk> NHjTPVAyODEQvF2= MlnhNYg> NYXtV5dz[W62YXfvcol7\XNiSH;pZY1q\GViQT3JcoR2[2WmIF7leZJwfG:6aXPpeJk> M1TZc|I2Pjd3MECx
Primary human placental cytotrophoblasts M3;2dWFxd3C2b4Ppd{BCe3OjeR?= MojYN|DPxE1? NX\Db|JoOjSq MormSG1UVw>? MYXy[ZZmenOnczD0bIUhcW6qaXLpeIlwdiCxZjCxNe6zNUiVREKgZpkhfHKrY3zvd4FvyqB? M1\U[lI2PjR{NUmy
MM MX;BdI9xfG:|aYOgRZN{[Xl? NELoR5A2OM7:TR?= M{DNRVIxdWmw M{jUXpBienSueTDpcohq[mm2czDTTGsucW6mdXPl[EAh[2WubDDk[YF1cA>? NVL6W4FJOjV3M{CwPVg>
DLD1 NFTz[JBCeG:ydH;zbZMhSXO|YYm= NH\RVG4zOMLizszN MoLSNYg> M2\XS5BienSueTDy[ZZmenOnczDj[YxtKGGyb4D0c5NqeyClYYXz[YQh[nliV2PQNS=> M4j2Z|I2PTJ2MkS2
MDA-MB-231 Ml60R5l1d3SxeHnjbZR6KEG|c3H5 MmTzNVDPxE1? MWmxbC=> NX[xZppq[XWpbXXueJMh[2WubDDk[YF1cCCjZoTldkBEUFWDIITy[YF1dWWwdB?= NWTr[Fc{OjV3MkG1NFE>
MKN28 MUjBdI9xfG:|aYOgRZN{[Xl? M{\EXFEx|ryP MmntN|BucW5? NH;KcmRFVVOR MYfpcohq[mm2czDUUmYu|rFicHz1d{BEUFhvaX7keYNm\CCjcH;weI9{cXN? MYeyOVUyOzl4MB?=
HL-60 NHzr[ZlEgXSxdH;4bYNqfHliQYPzZZk> NGfvfHUyODEQvF2= NV7rdJNsOWh? M3f6Z2ROW09? MmLSxsBqdXC{b4\ld{B3cWGkaXzpeJkhd2ZiVFPORZMufHKnYYTl[EBk\Wyucx?= NX7q[JRIOjV3MEK5N|I>
AGS NXLVOpY6SXCxcITvd4l{KEG|c3H5 M1;aNVEx|ryP NIXCUG4ycA>? NGDTS|JxemW4ZX70d{BkfXKldX3pck1qdmS3Y3XkJINt\WG4YXflJI9nKGOjc4Dhd4UuOyxiLUisJIFv\CBvOTDwdo91\Wmwcx?= Mki3NlU1QTJ{MUS=
A549  MnTKRZBweHSxc3nzJGF{e2G7 MVuxNO69VQ>? MnfsNlRp NWPVbWtO[myxY3vzJGROSVNvaX7keYNm\CClbHXheoFo\SCxZjDjZZNx[XOnLUOgZY5lKFCDUmCgZY5lKGGyb4D0c5Rq[yClZXzsJIRm[XSq M3rHcVI2PDN2OUi5
INS-1 Mlj3RZBweHSxc3nzJGF{e2G7 M3\MWVUx|ryP M33jSlZp NFP5VoZFVVOR MlXV[IVkemWjc3XzJJRp\SCycn;wc5J1cW:wIH;mJIViemy7IHHwc5B1d3SrYzDj[Yxte8Li MnLtNlU1OzB6OUe=
Primary hepatocytes  M2XqOmFxd3C2b4Ppd{BCe3OjeR?= NFH6bVg2OM7:TR?= M3XkV|E5cA>? M3vt[IlvcGmkaYTzJIFxd3C2b4Ppd{Bw\iCqZYDheI9kgXSnczDpcoR2[2WmIHL5JGFkfCCGIHHu[EBVVkZvzsG= MkjKNlU1ODd3M{i=
L929-A  MnTZR5l1d3SxeHnjbZR6KEG|c3H5 NVjXNJFROjEEoN88US=> M3LTNFI1cA>? M3nYdYlvcGmkaYTzJHRPTs7zLXnu[JVk\WRiY3XscEBl\WG2aB?= M4flV|I2Ozl6NUSw
L929-N NGjXNXBEgXSxdH;4bYNqfHliQYPzZZk> NX\rcFRGOjEEoN88US=> M1e3RVI1cA>? NX;4b2U5\W6qYX7j[ZMh\GWjdHigeoliKGG3dH;jdolv\SCWTldOtUBxem:mdXP0bY9v MkS2NlU{QTh3NEC=
Cytotoxicity Assay MlH0R4VtdCCYaXHibYxqfHliQYPzZZk> M3frU|Ix|ryP NILrSoQ1QGh? NXrmVHlVeHKndnXueEBOUE2GLXnu[JVk\WRiY3XscEBl\WG2aB?= MlXpNlU{QTJzMU[=
COS7 NYjrT25lU2mwYYPlJGF{e2G7 NVqwNmI6OTEQvF2= MV:yOIg> MULpcoNz\WG|ZYOgZ4F{eGG|ZTCzM|ch[WO2aY\peIlmew>? NUT1bJZCOjV|OESwNlU>
COS7 MV\BdI9xfG:|aYOgRZN{[Xl? NYPacoFvOTEQvF2= Ml\XOFhp MXvwZZJ1cWGubImgdJJmfmWwdHXkJGZEOTBzLXnu[JVk\WRiY3XscEBl\WG2aB?= M1;0NVI2Ozh2MEK1
A375 MnvSRZBweHSxc3nzJGF{e2G7 NXT3c|A4OzEQvF2= M33ZdFJp NYizRYZKeHKndnXueJMhfGinIHTyeYcucW6mdXPl[EBRSVKSIHPs[YF3[Wen NHz3fG8zPTN5NkGxOS=>
A549 Mn;BRZBweHSxc3nzJGF{e2G7 NGTzfnc2OM7:TR?= NGLKfmIzPGh? NHHFdGZz\X[ncoPld{BzcWKxc3;t[UBjcW:pZX7ld4l{KGGwZDDhdI9xfG:|aYOgZ4F2e2WmIHL5JEBEcGmsb37n[IFv MmfrNlU{PDl5OEG=
A549 NFO2eYpCeG:ydH;zbZMhSXO|YYm= NXX3epdTOi53LUK1{txO NYjOS5BnOWh? NEPFcohl\WO{ZXHz[ZMhfGinIIDvdJVt[XSrb36gc4Yh[XCxcITveIlkKGOnbHzzJIRmeGWwZDDvckBkd26lZX70doF1cW:wcx?= MUiyOVM1OjR{Nx?=
 NBL-W-S  NUHtSnl3SXCxcITvd4l{KEG|c3H5 NIe5UVg2OM7:TR?= NUjibW57OWh? MXPmeYxtgSC{ZYPjeYV{KGOnbHygeoli[mmuaYT5JIFnfGW{IFfBUnQuPjFidILlZZRu\W62 NIWzZm8zPTN{M{KyNi=>
Caki-1  NHrGSlNCeG:ydH;zbZMhSXO|YYm= MYe0NO69VQ>? NGrHeJk1QGh? MWHy[YR2[2W|IITo[UBvfW2kZYKgc4YhSW6wZYjpckBXNXCxc3n0bZZmKGOnbHzz MXqyOVI4QTF7MR?=
769-P NVz2N2o6SXCxcITvd4l{KEG|c3H5 M1nacFQx|ryP MWK0PIg> MkL5doVlfWOnczD0bIUhdnWvYnXyJI9nKEGwbnX4bY4hXi2yb4PpeIl3\SClZXzsdy=> NHfPe2ozPTJ5OUG5NS=>
H9c2 NYH3VYkzSXCxcITvd4l{KEG|c3H5 M4KwblUx|ryP M3ruUFFp NFH0[WxqdmirYnn0d{BFV1hvaX7keYNm\CClYYPwZZNmKDNiYXP0bZZifGmxbjDieZQhdm:2IITo[UBtd3O|IH;mJINmdGy| Ml7kNlUzQDN6MUm=
K562 M1OxVmFxd3C2b4Ppd{BCe3OjeR?= MVO1NO69VQ>? M2nRNFRp NHH0U5RqdmirYnn0d{BL[WNvQT3pcoR2[2WmIHPlcIwh[XCxcITvd4l{ MYqyOVI1OTZzOR?=
L929 MkTIRZBweHSxc3nzJGF{e2G7 MYqxNO69VQ>? MnXJOog> M2XPS4lv\HWlZYOgcoVkem:ydH;zbZMhf2m2aDDUUmY> M2q1N|I2OTl3Nk[w
A549 NU\3SW9VSXCxcITvd4l{KEG|c3H5 Mmr1NVDPxE1? M4ja[VNp MY\y[YR2[2W|IHPlcIwh[XCxcITvd4l{KGOjdYPl[EBjgSCSUWG= MWWyOVE3OTZ7OR?=
MCF-7 NVPrNYxySXCxcITvd4l{KEG|c3H5 MnT4NlDPxE1? NX\0[m0zOmh? M{jMUIRm[3KnYYPld{BMTFJvc3nSUmEucW6mdXPl[EBieG:ydH;zbZM> M3fSO|I2OTh{MkSw
OS Mlv5RZBweHSxc3nzJGF{e2G7 NFXGbVYzOC92MN88US=> Mn;mO|Jp M4rhNolvcGmkaYTzJG9UKGOnbHygeoli[mmuaYT5JJJm\HWldHnvckBjgSCFNjDj[ZJidWmmZR?= NWHsfFUyOjVzNUKzPVk>
HUVECs MnLRRZBweHSxc3nzJGF{e2G7 NGfXRYMyOM7:TR?= M2G1VFJp MljqxsBqdmirYnn0d{BieG:ydH;zbZMh[W6mIH\hZ4ltcXSjdHXzJIF2fG:yaHHnfUBqdiCGRV7WNk1qdm[nY4Tl[EBJXV[HQ4O= NW\IXW9WOjVzM{i3NFM>
EA.hy926 M1XZ[WFxd3C2b4Ppd{BCe3OjeR?= MW[xNO69VQ>? NIDVS3gzcA>? M3nyVuKhcW6qaXLpeJMh[XCxcITvd4l{KGGwZDDmZYNqdGm2YYTld{BifXSxcHjh[5khcW5iRFXOWlIucW6oZXP0[YQhTUFwaIm5NlY> NF36W4QzPTF|OEewNy=>
Ebs M4TwSmFxd3C2b4Ppd{BCe3OjeR?= M1LCRlExNTFyMN88US=> NHfDb4IzPGh? MlXZxsBOVVSVIHflcoVz[XSrb36gdoF1\SCmZXPy[YF{\WRiYYOgeIhmKGOxbnPlcpRz[XSrb36gc4Yhgi2YQVSu[o1sKGmwY4LlZZNm\A>? M4nhdFI2OTN2OEG3
Jurkat Mnq3RZBweHSxc3nzJGF{e2G7 M2[wOlIx|ryP M2XjOVI1cA>? NY\ySlVwTE2VTx?= MWPwZZJ1cWGubImgbY5pcWKrdDDj[YxtKGSnYYToJI9nKEq3cnvheEBk\WyuczDpcoR2[2WmIHL5JFExODV6LV[0JINwdWKrbnXkJJdqfGhiVmDBxsA> NYDHS2huOjVzMkC3NlM>
K562 MlrPRZBweHSxc3nzJGF{e2G7 M1Prc|AvOS1zzszN MkLzNYg> MW\pcohq[mm2czDjcIVifmGpZTDv[kBJW1B7MDDpckBiKGSxc3Wt[IVx\W6mZX70JI1idm6nch?= MlPxNlUyOTlzOEi=
IMR-32 NVTLPG5sSXCxcITvd4l{KEG|c3H5 NWf3dJFMPDEEoN88UeKh Mn3hNog> M3H3eoRm[3KnYYPlJIlvKGGyb4D0c5Rq[yClZXzsd{Bkd22yYYLl[EB1dyCWLUKgeI95cW5? M1XhN|I2ODh2N{W1
RPMI 8226 M17YdmFxd3C2b4Ppd{BCe3OjeR?= M2GwbFExOM7:TR?= NUPVTYh1OWh? MYThcI1we3RiY3;tdIxmfGWueTDicI9kc3NiY3XscEBl\WG2aDDjZZV{\WRiYomgcoVkem:|dHH0bY4uOQ>? NWLBeZJKOjVyM{e4OVE>
U266  NWntblhySXCxcITvd4l{KEG|c3H5 M3;VcVExOM7:TR?= MmjjNYg> MWDwZZJ1cWGubImgZoxw[2u|IHPlcIwh\GWjdHigZ4F2e2WmIHL5JI5m[3Kxc4TheIlvNTF? NIfPSlMzPTB|N{i1NS=>
H929  NGD5W2lCeG:ydH;zbZMhSXO|YYm= NIOwdHgyODEQvF2= M2Hs[VFp NHu4d|Nx[XK2aXHscJkh[myxY3vzJINmdGxiZHXheIgh[2G3c3XkJIJ6KG6nY4Lvd5RifGmwLUG= MVWyOVA{Pzh3MR?=
MM.1S  NYfheo9qSXCxcITvd4l{KEG|c3H5 MY[xNFDPxE1? NXq4RpVOOWh? NF7BdpVm\m[rY3nlcpRtgSCycnX2[Y51eyC|b4Lh[oVvcWJvaX7keYNm\CClZXzsJIRm[XSqIHPvcYJqdmVid3n0bEBv\WO{b4P0ZZRqdi1z M1O5[FI2ODN5OEWx
C6 NWrTfFFPSXCxcITvd4l{KEG|c3H5 MUC1NO69VQ>? MnnrOFhp Mlu4dJJmfmWwdIOgeIhmKGyxc4Ogc4Yh[2WubDD2bYFjcWyrdImgZ4F2e2WmIHL5JJBz\WewZX7vcI9v\Q>? M3TZbFI2ODF|NEe5
AGS Mnu3RZBweHSxc3nzJGF{e2G7 MUW1NO69VQ>? M17HUFI1cA>? MWLhZo9tcXOqczFOtk1t[XCjY3jvcoUucW6mdXPl[EBk\WyuIHTlZZRpKGGwZDDpcohq[mm2ZXSg[5Jwf3Sq NVTZNWlwOjVyMEm2PVg>
HeLa  NE\YSJZCeG:ydH;zbZMhSXO|YYm= MkftOFDPxE1? M3vEbVI1cA>? MkfobY5pcWKrdIOgeIhmKGmwY4LlZZNm\CCjcH;weI9{cXNiaX7keYNm\CCkeTDzbXJPTjF{MR?= NY\4UYo1OjR7Mki2PFU>
THP-1  M360TWFxd3C2b4Ppd{BCe3OjeR?= NH\4UIcyOM7:TR?= NUfvS4c3OWh? MYny[YR2[2W|IHHwc5B1d3OrczDpcoR2[2WmIHL5JGFNSS2VRGVCpC=> NV3mT291OjR7MkO2OVM>
P815  Mo\rRZBweHSxc3nzJGF{e2G7 MWixNFAhyrWP NY\qepFkOTKq NUP3WmR[TE2VTx?= M3PLPIlvcGmkaYTzJJZqenW|LXnu[JVk\WRiYYDvdJRwe2m| NEL2O|YzPDl{M{K3Ny=>
HCT116 NX7tb5dmSXCxcITvd4l{KEG|c3H5 NIrQVGUzOM7:TR?= M1PST|I1cA>? NYjJd5VT[WK{b3fheIV{KG:oIGTRMYlv\HWlZXSgZZBweHSxc3m= MWiyOFg6ODR2OR?=
SW1116  NHXyRpBCeG:ydH;zbZMhSXO|YYm= Ml[xNVAhyrWP NEPOTmMycA>? MkXrSG1UVw>? M2jVbZJme3S{YXnud{Bk\WyuIHHwc5B1d3OrczDpcoR2[2WmIHL5JIdm\mm2aX7pZkBxdHW|IHTlZ4l1[WKrbnW= MXSyOFg4PDJ6Nh?=
LOVO M4Kzd2Fxd3C2b4Ppd{BCe3OjeR?= NWLFPWZUOTBiwsXN MmjRNYg> MmX6SG1UVw>? MlvndoV{fHKjaX7zJINmdGxiYYDvdJRwe2m|IHnu[JVk\WRiYomg[4VncXSrbnniJJBtfXNiZHXjbZRi[mmwZR?= NXPSc4MxOjR6N{SyPFY>
SNU449  M1jaOWFxd3C2b4Ppd{BCe3OjeR?= M321UVIx|ryP MlPYOFhp MUDEUXNQ NXHwXVNG\GWlcnXhd4V{KG2rUj20OVEucW6mdXPl[EBieG:ydH;0bYM> MnrnNlQ5PDF4M{i=
Caco-2 M4i3T2Fxd3C2b4Ppd{BCe3OjeR?= NYjaXHhXPDEkgJpOwG0> MmjwOIg> Ml3ldJJmfmWwdIOgV3QuPy2rbnT1Z4VlKFqRLUGgZ4hidmenczDhcoQhXEWUIHTyc5A> M3PrTVI1QDJ{MUiz
macrophage MkXvR4VtdCCYaXHibYxqfHliQYPzZZk> M4nuNVAuOjByzszN NH:2bJozPGh? MXPpcoR2[2W|IGTOSk0h[W6mIGLpdFMu\GWyZX7k[Y51KG6nY4LvdJRwe2m|IHnuJI1i[3KxcHjh[4U> NHH0cYgzPDd7OUW2OS=>
AGS  MVrBdI9xfG:|aYOgRZN{[Xl? MmjTNlDPxE1? M4T2fVEzcA>? MoH6SG1UVw>? NXfHW4loemWmdXPld{B1cGViaX7keYN1cW:wIH;mJIFxd3C2b4Ppd{BqdiC{ZYPwc45{\SC2bzD0bIUhTXSRQXOg[pJi[3Srb36gbY4h[SCmb4PlMYRmeGWwZHXueEBu[W6wZYK= NXHlSnJCOjR5OEm3NFM>
LCC9  NF3QdmtE\WyuIG\pZYJqdGm2eTDBd5NigQ>? Mn[1NVAx|ryP NECzc4g2\A>? M2LBTYJtd2OtczDj[YxtKGSnYYToJIlv\HWlZXSgZpkh[2:vYnnuZZRqd25iTEG3JIFv\CClaHzvdo9yfWmwZR?= MnvrNlQ4QDV{NU[=
U937  NXrLeJZYdmWlcn;weI9{cXNiQYPzZZk> MlXnNVDDqM7:TR?= NEHvdmw{OMLibXnu MnHObY5lfWOnczDu[YNzd3C2b4Ppd{Bkd22kaX7lJJdqfGhiVF7G NILCTmQzPDd5M{e1Oi=>
T cell MoHhR4VtdCCycn;sbYZmemG2aX;uJIF{e2G7 NYHjeYZVOC1zMEFOwG0> MlfoO|Jp M1;zcWlEPTB;N{Cg{txONCCrbnjpZol1eyCjboTpMWNFOy2rbnT1Z4VlKFRiY3XscEBxem:uaX\ldoF1cW:wIHnuJHBDVUO| NHOze3QzPDd4OEewOy=>
HeLa  NWTUVo9mSXCxcITvd4l{KEG|c3H5 MWO1NO69VQ>? MWC3Nog> NXHHO21KTE2VTx?= MXrwdoV3\W62czDhdI9xfG:|aYOgbY5lfWOnZDDifUBkd22yb4Xu[JPDqDIkgKO1 MlfHNlQ4PTR5OE[=
HeLa  NGCwVYdCeG:ydH;zbZMhSXO|YYm= MXKxNFDPxE1? MV2yOIg> M4LRd5N2eHC{ZYPz[ZMhemG2ZTDv[kBk\WyuIHTlZZRpKGmwZIXj[YQh[nlib4\ldoV5eHKnc4Ppc44hd2ZiR{W5V{BweiCJN{HSJJAyPTCpbIXl[OKh MXmyOFczOjR4OB?=
IEC-6  MX;BdI9xfG:|aYOgRZN{[Xl? NWLSWmZPOTEQvF2= Mn3zNlRp MXnwdoV3\W62czDUZ4RCNWmwZIXj[YQh[2G|cHHz[U0{KGOuZXH2ZYdmKGGwZDFOtk1k[XSnbnnuJIRm\3KjZHH0bY9v Mn3WNlQ4OTF3N{G=
HCT116 NXfMTHhOSXCxcITvd4l{KEG|c3H5 NXPNXXR[OjEQvF2= NXLjb5N[OjSq MmLXbY5pcWKrdIOgeIhmKGOnbHygZZBweHSxdHnjJIlv\HWlZXSgZpkhYUyWMkC1 NXfiUVNxOjR5MUO4NVI>
L02 Mme4RZBweHSxc3nzJGF{e2G7 NHHURWQzOM7:TR?= NFi1NlcycA>? M4TCVpBz\X[nboTzJJRp\SClZXzsJIFxd3C2b4Ppd{BqdmS3Y3XkJIJ6KE2HSGC= Mnm2NlQ4ODZ2NkG=
A375 NFThOnlCeG:ydH;zbZMhSXO|YYm= NUj1XYg4OjEQvF2= M1TFWVI1cA>? NGnRXndz\X[ncoPld{BlcWOrdILpco9v\SCELXnu[JVk\WRiYYDvdJRwe2m| NV3YSIQyOjR4OUmxNVE>
HDPC Mln4RZBweHSxc3nzJGF{e2G7 NU\l[2QzPTEEtV2= Mn;1NlRp NEL5cIdqdmirYnn0d{BPVy2rbnT1Z4VlKGGyb4D0c5Nqew>? M17RPVI1PjN2NUmz
A549 MWHBdI9xfG:|aYOgRZN{[Xl? MnfBOVDDvU1? M1nSWlJp M2\pU2ROW09? NGH2fHZxemW4ZX70d{B1cGViaInwc4RqeGyxaXSgSG5CKGOxboTlcpQheGijc3WgbY5lfWOnZDDifUBk\XCqYXzvZ4hzd22rbh?= NH22[pgzPDV6OEGzOS=>
 BV-2 NWPXTFJ7SXCxcITvd4l{KEG|c3H5 M1m2O|Ix|ryP M2TVOVJp MVPzeZBxemW|c3XzJHVXNWmwZIXj[YQh[2i{b33heIlvKGW6dIL1d4lwdiCjbnSg[Ilt[XSrb36gc4YhfGinIH71Z4xm[XJiZX72[YxweGV? M3\OR|I1PTV6MUG4
HT-29  NHjrbXBCeG:ydH;zbZMhSXO|YYm= MlXNOVDPxE1? NXnTO5BmPDiq M{XTS4Jtd2OtczD0bIUh[XCxcITvd4l{KGmwZIXj[YQh[nlia3HlcZBn\XKxbB?= M4rqR|I1PTR7MUe1
A549 NEfqbGJCeG:ydH;zbZMhSXO|YYm= NUTueHYyPc7:TR?= MXyyOIg> MWnzeZBxemW|c3XzJFZmyqBqQluxNFA1OClvaX7keYNm\CCjcH;weI9{cXQEoB?= NIfOUW0zPDV{OUi3NS=>
MIA-PaCa-2 NGDkfJhCeG:ydH;zbZMhSXO|YYm= MYCyOIg> M2rRU4Jtd2OtczDjcIVifmGpZTDv[kBk[XOyYYPlMVMhcW6mdXPl[EBjgSCkb4ToJGEuPDR|NkW0JIFv\CCyYXPsbZRigGWu MYKyOFUyODl7Mh?=
Caki-1 M1HuTGFxd3C2b4Ppd{BCe3OjeR?= NEWwbZozOM7:TR?= MkTnNYg> MUjpcohq[mm2czDTR3AucW6mdXPl[EBieG:ydH;zbZM> MmDtNlQ2ODR4OEG=
CLL M{X6[WFxd3C2b4Ppd{BCe3OjeR?= M4HNO|I2|ryP MmHhNYg> MmG3dIFzfGmjbHz5JIJtd2OtczDNUG4zOjN6LXnu[JVk\WRiY3XscEBieG:ydH;zbZM> NG\mT|EzPDR4N{[zOC=>
SGC-7901 MXzBdI9xfG:|aYOgRZN{[Xl? NUHHVWRFOTEQvF2= M2TJR|I1cA>? Mlq3dJJwdW:2ZYOgeIhmKEOJSVmtbY5pcWKrdHXkJINmdGxiZ4Lve5RpKGmwIGPHR{04QTBzIHPlcIx{ Mo\4NlQ1PTR2OEi=
k1735 NHXPflVCeG:ydH;zbZMhSXO|YYm= NIWwVpAzOOLCid88cS=> NHixcmY1cA>? MV\pcohq[mm2c9MgV4FtdW:wZXzsZU1qdmS3Y3XkJIFxd3C2b4Ppdy=> NWDPZpFHOjR2NUGxNVY>
HaCaT  NH\pN2NCeG:ydH;zbZMhSXO|YYm= Mn:2NVAx|ryP NXTxNXd5OWh? M17vPYJtfW62czDVWmIucW6mdXPl[EBieG:ydH;zbZMhcW5iSHHDZXQh[2WubIO= NXPUSYhsOjR|NU[5PVc>
podocytes NUPmNmlISXCxcITvd4l{KEG|c3H5 NVPQNJBYOjByzszN M1XWOlZp NGfPVIlqdmirYnn0d{BieG:ydH;zbZMhcW6mdXPl[EBjgSB|LEStSGdG M2myOFI1OzN5N{e3
 KB NWTHT4hsSXCxcITvd4l{KEG|c3H5 NHfnZ4c2OM7:TR?= M3\0elI1cA>? MoT0bY5pcWKrdIOgUIlkdy2DLXnu[JVk\WRiY3HzdIF{\S1|IHHu[EBRSVKSIHHjeIl3[XSrb36= M4L3ZlI1OzN5NEmy
 HepG2  NFrzWW1CeG:ydH;zbZMhSXO|YYm= MXOxNO69VQ>? MXuyOIg> NITENVdz\WS3Y3XzJJZqdWWwdHnuJINt\WG4YXflJINifXOnZDDifUBNWFN? NU[0NnpYOjR|MkW4NVY>
fetal rat lung fibroblasts  NHLMTWRMcW6jc3WgRZN{[Xl? NV;HSZo5QDEQvF5CpC=> MoP0NYg> M{K0SIlvcGmkaYTzJGNie3Cjc3WtN{Bi[3Srdnn0feKh MmfpNlQ{OTRzM{W=
PDL fibroblasts MknsT4lv[XOnIFHzd4F6 NIPIfJA5OM7:TdMg M4rlU|Fp NHzkW|FqdmirYnn0d{BE[XOyYYPlMVMh[WO2aY\peJnDqA>? NIXGR20zPDNzNEGzOS=>
MB49 Mn\YRZBweHSxc3nzJGF{e2G7 NWW4RoNFOjEQvF2= Mmr4NYg> M3iyPZJmfmW{c3XzJGNONWmwZIXj[YQh[2WubDDk[YF1cA>? NXi3em9rOjR{OEK0N|M>
5637 MlfmRZBweHSxc3nzJGF{e2G7 M2HIbVIx|ryP MVuxbC=> NUTWNoJnemW4ZYLz[ZMhS01vaX7keYNm\CClZXzsJIRm[XSq M1TQbVI1Ojh{NEOz
A549  NEHnSXFCeG:ydH;zbZMhSXO|YYm= NV;5bZd6OTByzszN MoHIOFhp NGXlUIt{fXCycnXzd4V{KHSqZTDhdI9xfG:|aYOgZ4F2e2WmIHL5JJBqeGW{aX7lxsA> NG\3b3EzPDJ5MkKwNS=>
MCC-2 MoO1RZBweHSxc3nzJGF{e2G7 NXjXVoFuOjBizszN MV62bC=> NH\ucG1FVVOR MVLicI9kc3NiaX7keYNm\CCkeTDzeIF2em:|cH;ybY5mKGGyb4D0c5NqeyClZXzsJIRm[XSq M1zzVFI1OjZ{NkW4
ADF NVnheZppSXCxcITvd4l{KEG|c3H5 Mn;OOFDPxE1? NUK1fZg1Pmh? NWTXRVlQcW6qaXLpeJMh[XCxcITvd4l{KGmwZIXj[YQh[nliY3jlcY91cGW{YYD5JJBtfXNiWn7DcFI> NYC4UFZnOjR{MkiyN|I>
 U373  NIrFXlNCeG:ydH;zbZMhSXO|YYm= NY\1WFdXPDEQvF2= NI[yRVg3cA>? NFnNeoRqdmirYnn0d{BieG:ydH;zbZMhcW6mdXPl[EBjgSClaHXtc5Rp\XKjcImgdIx2eyCcblPsNi=> NVrDfHBHOjR{MkiyN|I>
RKO-HIPK2i MXzBdI9xfG:|aYOgRZN{[Xl? NGGzcYc1OM7:TR?= NVz2TmY4Pmh? MVzpcohq[mm2czDhdI9xfG:|aYOgbY5lfWOnZDDifUBkcGWvb4To[ZJieHlicHz1d{BbdkOuMh?= MV[yOFIzQDJ|Mh?=
HEC-1B M3nJ[WFxd3C2b4Ppd{BCe3OjeR?= M17NRlIx|ryP MlTjNYg> MoPMdoVlfWOnczDUVE1qdmS3Y3XkJIFxd3C2b4Ppd:Kh[2G|cHHz[U0{KGGwZDDjZZNx[XOnLUm= MV2yOFIyOzN3OB?=
4T1 MXTD[YxtKF[rYXLpcIl1gSCDc4PhfS=> MW[yMlUuOTEQvF2= M{DaOlRp NVfEW21nTE2VTx?= NFT5boZz\XOldXXzJJRp\SCleYTveI95cWOrdImgc4YhPFRzIHPlcIx{KGmwZIXj[YQh[nliU2DEWEBqdiCjIHPvcoNmdnS{YYTpc44h\GWyZX7k[Y51KG2jbn7ldi=> MojmNlQzODZzNkG=
OS  Mk\iRZBweHSxc3nzJGF{e2G7 M4G4ZlIx|ryP MV[0bC=> NHPpfXdqdmirYnn0d{B1cGViY3XscEBl\WG2aDDjZZV{\WRiYomgVGRV NEnHW5MzPDJyNEmzOy=>
RPE M4PoNWFxd3C2b4Ppd{BCe3OjeR?= NELrXYgyODEQvF2= MXW0PIg> NUfMV4o2eGG{dHnhcIx6KGmwaHnibZR{KHSqZTDjZYxx[WmwLUGgZY5lKC1{IHHjeIl3[XSrb36gZZMhf2WubDDhd{B1cGViY3HzdIF{\SCjY4TpeoF1cW:w MmnUNlQzODJyNUK=
UD29a Mn3oRZBweHSxc3nzJGF{e2G7 NGG5bmc2OM7:TR?= NH7LXoUzPGh? NWTWZpBIcW6qaXLpeJMhfGinIHPlcIwh\GWjdHigZ4F2e2WmIHL5JG5WXDN? MlrkNlQyQTB3N{S=
SH-SY5Y  MVnBdI9xfG:|aYOgRZN{[Xl? NXrle49xOTEQvF2= NFjzemgzPGh? M1jUdoF1fGWwdXH0[ZMh[2G|cHHz[UBi[3SrdnH0bY9vKGGwZDDj[YxtKGSnYYToJIlv\HWlZXSgZpkhUE6HLULESy=> Mlq5NlQyPDV2NkO=
HeLa  NVH3PZFpSXCxcITvd4l{KEG|c3H5 M4XtUlExNzJyzszN MlLUNlRp NFjWbZRqdmirYnn0d{B1cGViYXP0bZZqfHlib3[geIhmKG2jan;ybZR6KG:oIITo[UBu\W2kZYLzJI9nKHSqZTDjZZNx[XOnLX\hcYltgQ>? MmW0NlQyOzd{Nk[=
SCCVII  M1q4ZWFxd3C2b4Ppd{BCe3OjeR?= NYf4[25XOjYQvF2= NGrqTZMycA>? MX\pcohq[mm2czD0bIUh[2WubDDrbYxtcW6pIHHmeIVzKGSjc3H0bY5q[g>? MW[yOFEzPjR4NB?=
RAW 264.7 NWHJUnNISXCxcITvd4l{KEG|c3H5 MVGyNO69VQ>? MXWxPIg> NXG5cohGcW6lcnXhd4V{KEyFMz3JTU/Pui2jY4TpckBz[XSrbzDjc41x[XKnZDD0c{BGS1SYLV3PV{B1emWjdH3lcpQhd26ueR?= MXuyOFEyPjdyNx?=
A549  M1G0NGFxd3C2b4Ppd{BCe3OjeR?= NF75Z|MzNjYQvF2= NXfWPXFrOjSq MVXk[YNz\WG|ZYOgc5Jq\G:waX6tbY5lfWOnZDDheZRweGijZ4mgZZMhf2WubDDhcoQhVG:|czDv[kDPnM,KbTDhcJNwKG:lY4XydoVlKGS3cnnu[{BifXSxcHjh[4lkKHC{b3Pld5M> MUOyOFExOjV{Mh?=
UM-SCC-10A  MY\BdI9xfG:|aYOgRZN{[Xl? NXTxTW5TPTEEtV2= M{P1NVJp MnfpdoVlfWOnczDhdI9xfG:|aYOgbY5lfWOnZDDifUBpcWeqLXTvd4UhcXOxYXzhcpRwdGGldH;u[S=> MVmyOFA6QDd3Mx?=
BGC-823 NWO5boRmSXCxcITvd4l{KEG|c3H5 M4nPcVExKM7:TR?= MUOyOIg> MnPEdoVlfWOnczD0[ZRz[W6mcnnu[U1qdmS3Y3XkJIFxd3C2b4Ppd:Kh NXeweZNkOjRyOUi1NVE>
Nalm-6  Ml\rRZBweHSxc3nzJGF{e2G7 NF\WfY0zOM7:TR?= NImyNJg1cA>? NEfIZXlqdmirYnn0d{Bk[XOyYYPlMVgh[W6mIHPhd5Bie2VvMzDhZ5RqfmG2aX;uJIFv\CCSQWLQMVEh[2ynYY\h[4U> NIDZWWMzPDB|OUm2Oy=>
KHOS  MYDBdI9xfG:|aYOgRZN{[Xl? MkTmOFDPxE1? Mn\QNlRp Mor2Zoxw[2u|IITo[UBqdmO{ZXHz[YQh[2ynYY\h[4Uhd2ZiY3HzdIF{\S1|IHHu[EBRSVKSIHnu[JVk\WRiYomgRmJOTDQEoB?= MnHHNlQxOjV|NkG=
G292 MmnvRZBweHSxc3nzJGF{e2G7 MVO0NO69VQ>? M{LoOFI1cA>? MmfIZoxw[2u|IITo[UBqdmO{ZXHz[YQh[2ynYY\h[4Uhd2ZiY3HzdIF{\S1|IHHu[EBRSVKSIHnu[JVk\WRiYomgRmJOTDQEoB?= M1nhVVI1ODJ3M{[x
MG-63 Ml3xRZBweHSxc3nzJGF{e2G7 MlvpOFDPxE1? NV7yVVN6OjSq M{W0NIJtd2OtczD0bIUhcW6lcnXhd4VlKGOuZXH2ZYdmKG:oIHPhd5Bie2VvMzDhcoQhWEGUUDDpcoR2[2WmIHL5JGJDVUR|wrC= MUKyOFAzPTN4MR?=
EBV-transformed B cells NEHEfGtCeG:ydH;zbZMhSXO|YYm= MW[yNO69VQ>? MUCybC=> MlHzSG1UVw>? Mn3DZoxw[2u|IHHueIkuS0R6MDDhcoQh[W62aT3DSFg3KGGwdHnic4R6NWmwZIXj[YQh[XCxcITvd4l{ MnjENlQxODh4Mki=
IM-9 B MXLBdI9xfG:|aYOgRZN{[Xl? NUD1do1SOjEQvF2= Mn3jNog> MoT4SG1UVw>? NFTY[YdjdG:la4OgZY51cS2FREiwJIFv\CCjboTpMWNFQDZiYX70bYJw\HlvaX7keYNm\CCjcH;weI9{cXN? MkDoNlQxODh4Mki=
CNE1 NWq0clBkSXCxcITvd4l{KEG|c3H5 NInRN4wzOM7:TR?= NHHQ[oM1QGh? NV3LZnBv[myxY3vzJGxMNUFvaX7keYNm\CCjcH;weI9{cXN? M2m5blI{QTh3MEK5
CNE2 NFu4SGtCeG:ydH;zbZMhSXO|YYm= MXeyNO69VQ>? NULhcXIyPDiq M1PWbYJtd2OtczDMT{1CNWmwZIXj[YQh[XCxcITvd4l{ MoPXNlM6QDVyMkm=
HL-60 NHHlZ2VCeG:ydH;zbZMhSXO|YYm= MWC1NOK2VQ>? NYnmNFlxOWh? MUDEUXNQ M1LTNYlvcGmkaYTzJIFxd3C2b4Ppd{BqdmS3Y3XkJIJ6KEKDMUS1 MWmyN|k1QDd3MR?=
L929 MXjBdI9xfG:|aYOgRZN{[Xl? MkL5NU4zPeLCk{ZCpO69VcLi MWGyOIg> MYfheYdu\W62czDUUmbPuS2rbnT1Z4VlKG6nY4LvdJRwe2m|IHHu[EBifXSxcHjh[5k> NFjLTlczOzl2MUe2PS=>
Jurkat M3\yTmNmdGxiVnnhZoltcXS7IFHzd4F6 M4mydFLPxE1? M1rVW|Rp M3zNZpJmfmW{c3XzJIdzd3e2aDDpcohq[mm2aX;uJIFv\CEQsj3jZZRmdmmwIHTlZ5Jm[XOnIHL5JGhUNUGVQR?= MX:yN|g6PjB4MR?=
RAW264.7  Mn;hRZBweHSxc3nzJGF{e2G7 MVSxNEDPxE1? NULDXmFxOjSq Mlfq[IVkemWjc3XzJJRp\SCjcH;weI9{cXNiaX7keYNm\CCkeTDHRS=> NF7ic5gzOzh{MEKwNy=>
A431  Mnm0T4lv[XOnIFHzd4F6 MnjxOFDPxE1? M2HofVJp NVKzWmpp[myxY3vzJIZqe2W2aX6tbY5lfWOnZDDjcIVifmGpZTDv[kBk[XOyYYPld{BidmRiUFHSVC=> MUOyN|gxODB3OB?=
Jurkat NHK4bXJE\WyuIG\pZYJqdGm2eTDBd5NigQ>? NIrW[pEzPS1zMEFOwG0> NELO[Gs3cA>? MlOwbY5pcWKrdIOgfk1HSS2FTVutbY5lfWOnZDDj[YxtKGSnYYTo NIDxRXYzOzl|M{WzNi=>
COS-7  NVHkXZFITnWwY4Tpc44hSXO|YYm= NFLjVYQ2OML3TR?= NGjMU2ozPGh? M3vZRYFn\mWldIOgeIhmKHC{b3Pld5Nqdmdib3[gRXRPOXNid3n0bEBxd2y7UTD0doFkfHN? NEDQNWwzOzl|M{KwPC=>
CAL27 MXfBdI9xfG:|aYOgRZN{[Xl? NVvp[Hd[OTBizszN NHLENoczcA>? MnLhd5VxeHKnc4Pld{BEfXJvTmDzMZJm\HWlZXSgeoli[mmuaYT5JIJ6KHWyIITvJFkxLQ>? NFrU[FgzOzlzN{O5Oi=>
THP-1  MmDpRZBweHSxc3nzJGF{e2G7 NHrXbIoyOC13MN88US=> M1e0NVJp NVfMSpBYcW6qaXLpeJMh[XCxcITvd4l{KGmwZIXj[YQh[nlidILpdJRwdGmmZR?= MXWyN|kxODJ7OR?=
K562 NY\ubXN1SXCxcITvd4l{KEG|c3H5 NIPic2szOM7:TR?= MXy0PIg> NHPHb2hqdmirYnn0d{BieG:ydH;zbZMhcW6mdXPl[EBjgSB2LV3V NWO2XnZoOjN6N{[4NlY>
HL-60 M4fufWFxd3C2b4Ppd{BCe3OjeR?= NGfKNXEyODEQvF2= M3\DTVI1cA>? M3Lp[IlvcGmkaYTzJIFxd3C2b4Ppd{BqdmS3Y3XkJIJ6KGGkaXX0ZY5mKGSrdHXydIVv\XQEoB?= M3HaOVI{QDZ3N{e4
HeLa  MnzwRZBweHSxc3nzJGF{e2G7 NVLB[5l1OjEQvF2= M1\adFJp MXjpcohq[mm2czDEUW1RKGmwZIXj[YQh[XCxcITvd4l{ NEn6eI4zOzh4M{m2Oi=>
U251 MmTXRZBweHSxc3nzJGF{e2G7 NXTIcIljOjEQvF2= M2DhdFI1cA>? NVXUVHpkcW6qaXLpeJMh[2G|dHnjbY4hcW6mdXPl[EBIOi:PIIDoZZNmKGG{cnXzeEBidmRiYYDvdJRwe2m| MkfqNlM5OTZ6MU[=
HL-60 MnG1RZBweHSxc3nzJGF{e2G7 M17MblUxyrWP M1\heFRp MmnWZoxw[2u|IITo[UBkdGWjdnHn[UBw\iClYYPwZZNmNTNuID25MEBidmRiUFHSVEBqdmS3Y3XkJIJ6KD[| Mki0NlM5ODR5ME[=
Ec-109 NYfjXIRPSXCxcITvd4l{KEG|c3H5 MUOxNEDPxE1? NYjPOmFkPDiq MoO5doVxemW|c3XzJHBGNW2nZHnheIVlKEWlLUGwPUBk\WyuIHHwc5B1d3Orcx?= NUDT[VZEOjN5OEK2OFE>
RKO NXHkb21LS2WubDDWbYFjcWyrdImgRZN{[Xl? MW[xNEDPxE1? M4jGZ|I1cA>? M1vrUYlvcGmkaYTzJJRp\SCmZXPy[YF{\SCxZjDj[YxtKH[rYXLpcIl1gSClYYXz[YQh[nliRFHC MYqyN|c2QDB4NB?=
T98G NVOxN|g3S2WubDDWbYFjcWyrdImgRZN{[Xl? M3H2fVEuOTByzszN M16w[FI1cA>? MYLpcZBzd3[nczDj[YxtKH[rYXLpcIl1gSClb4Ty[YF1dWWwdDD3bZRpKFSV MmDtNlM4Pjl{N{W=
Jurkat NWK2[5VSS2WubDDWbYFjcWyrdImgRZN{[Xl? MWixNFAuOjByzszN M3jYR|I1cA>? MVTpcohq[mm2czDIZWE1KGmwZIXj[ZMh[XCxcITvd4l{KGSncHXu[IVvfCCxZjDjc45k\W62cnH0bY9vyqB? M3S1cFI{PzN{NEix
Molt-3  NEjUNoZCeG:ydH;zbZMhSXO|YYm= NHvPbIE2OM7:TR?= NXfHbGZtOmh? Mki1doVlfWOnczDt[YxifG:waX6tbY5lfWOnZDDhdI9xfG:|aYO= MYOyN|czPTBzMx?=
hMSC12 MmHSRZBweHSxc3nzJGF{e2G7 MXGxNFDPxE1? M1m1VlRl NH\afWVqdmirYnn0d{Bwe3Snb3flcolkKGO3bIT1doUucW6mdXPl[EBk\WyuIHTlZZRpKGGwZDDjZYxkcW[rY3H0bY9v M1LTOVI{PjV5OEKy
HM7  M2HPRWFxd3C2b4Ppd{BCe3OjeR?= MUiyNO69VcLi NX;tdnRnOWh? MVjicI9kc3NiYYDpZ5Vt[XKnbjDBJIFk\XSjdHWtbY5lfWOnZDDjZZNx[XOnLUOgZYN1cX[jdHnvckBidmRiUFHSVEBkdGWjdnHn[S=> MWWyN|U5OzRzMh?=
Hep-2  M4HsXGFxd3C2b4Ppd{BCe3OjeR?= MmDJNlDPxE4EoB?= MlK5NlRp NWPrdpdzTE2VTx?= MULhcIxmfmmjdHXzJJRp\SCmZXPy[YF{\SCxZjDj[YxtKH[rYXLpcIl1gSCrbnT1Z4VlKGK7IIPpcIljcW6rbh?= MlLINlM2QDByM{K=
HSCs MmnIRZBweHSxc3nzJGF{e2G7 MXq1NO69VQ>? NWH6bWlOOjSq M3zmWmROW09? NFXQTIJqdmirYnn0d{BvcWyxdHnubYIucW6mdXPl[EBFVkFiZHHtZYdmKGmwZHnjZZRm\CCkeTDQRXJRKGOuZXH2ZYdm NFnDbVUzOzR7OUi3OC=>
HL-60  M3f3V2N6fG:2b4jpZ4l1gSCDc4PhfS=> NUjmV|F5OjEQvF5CpC=> NIXvc4gzPGh? NYjVNmxFemWmdXPld{B1cGViY4n0c5RwgGmlIHXm[oVkfCCxZjDFdpk2 NVX1Zmd3OjN2OUS0PFA>
HA MoKxRZBweHSxc3nzJGF{e2G7 MVq1NO69VQ>? MnmwNlRp NHrrbG9{fXCycnXzd4V{KHSqZTDjcIVifmGpZTDv[kBRSVKSIHHu[EBk[XOyYYPlMVMtKC15LDDhcoQhNTliaX7keYNm\CCkeTDic5J1\XqxbXniM3NCUEF? NWToT2RGOjN2N{W5OVY>
C666-1 M4DIOmFxd3C2b4Ppd{BCe3OjeR?= M2[1fVUx|ryP NWi3OW9QOjSq NH7hR5d{fXCycnXzd4V{KHSqZTDjcIVifmGpZTDv[kBRSVKSIHHu[EBk[XOyYYPlMVMtKC15LDDhcoQhNTliaX7keYNm\CCkeTDic5J1\XqxbXniM3NCUEF? NVfmcHY4OjN2N{W5OVY>
Hepa1-6 MVXBdI9xfG:|aYOgRZN{[Xl? MWO1NO69VQ>? Ml\jNog> NXHYZlE4cW6qaXLpeJMh[3W{Y4XtbY4h[W6mIILld5ZmemG2cn;sMYlv\HWlZXSgZZBweHSxc3nz M1zKTFI{PDR4N{Wz
PLC/PRF/5c M3v3NWFxd3C2b4Ppd{BCe3OjeR?= Ml\oOVDPxE1? NFHGV4QycA>? NWfYZVcyeHKndnXueJMh[XCxcITvd4l{KHS{aXfn[ZJm\CCkeTDDTW4> MWSyN|Q{QDh{NB?=
HCT116 M4PodGFxd3C2b4Ppd{BCe3OjeR?= NGj2cJgyODEQvF2= NWj2NWJjOS53aB?= MoHZbY5pcWKrdIOgU5MucW6mdXPl[EBk\WyuIHTlZZRp NXXjeVcxOjN5NESzOVM>
HCEC M{fCbWZ2dmO2aX;uJGF{e2G7 NHX1fJk2OM7:TR?= MmnyO|Jp M2WxOmROW09? MYXy[ZN1d3KnczDv[kB1cGVibn;ycYFtKEiFRVOgdIhmdm:2eYDl NFfUXYwzOzd2MkCxNS=>
Primary rat cerebral cortical neurons MmLwRZBweHSxc3nzJGF{e2G7 MVWxNFDPxE1? MUKxbC=> MX3wdoV3\W62czDD[E1qdmS3Y3XkJIFxd3C2b4Ppd{BidmRiY3XscEBl\WG2aB?= NXW2cINPOjN5NEGzNVc>
MDA-MB-231  M17uT2Fxd3C2b4Ppd{BCe3OjeR?= M3:4N|I2|ryP NY\BdXA1OjSq MlXJZYJzd2ejdHXzJIN6fG:2b4jpZ4l1gSCjbnSgZ4xm[X[jZ3Wgc4Yh[2G|cHHz[U0{KGGwZDDQRXJRKGmwZIXj[YQh[nliUnez NE\PPHkzPTN|N{W0OC=>
NLRP3-Tet-on-MC/9  MWTBdI9xfG:|aYOgRZN{[Xl? MVOxNE01OM7:TR?= NWjVWXNUOTKq M3u5UIF1fGWwdXH0[ZMhfGinIHPlcIwh\GWjdHigZ4F2e2WmIHL5JGNCWFNvYYPzc4Nq[XSnZDDOUHJROyCvdYThcpR{KGmwIITo[UBV\XRvb36gd5l{fGWv MkHjNlM4ODN|OEm=
KNS42  MXfBdI9xfG:|aYOgRZN{[Xl? MYG1NO69VQ>? MX:xbC=> NW[5WWNHemWmdXPld{Bk\WyuIHTlZZRpKGGwZDDjc41xdGW2ZXz5JIFjd2yrc3jl[EBk[XOyYYPlJFMwPyCjY4Tpeol1gSCrbjDy[ZNxd26|ZTD0c{BCSlRvMk[zM|JFTy:vZYTmc5JucW5iY3;tZolv[XSrb36= NYH5boVvOjN4OUGxOFU>
MCF-7  NIHUfnVCeG:ydH;zbZMhSXO|YYm= M3rYelIx|ryPwrC= NHXDPJM4Omh? NHzH[4RqdmirYnn0d{BmeXWxbD2gZY5lKDRvT1jUMY1m\GmjdHXkJIFxd3C2b4Ppdy=> NInLcogzOzZ5NU[0Ny=>
hCMEC/D3  Mn75RZBweHSxc3nzJGF{e2G7 NIDrcWgzPc7:TR?= NFfDNJU4Omh? Mn3vdoVlfWOnczDMeJhCKGmwZIXj[YQh[XCxcITvd4l{ M3XoZlI{PjZ3MUm4
Jurkat MnzJRZBweHSxc3nzJGF{e2G7 NGPJeXQyOi53LUWw{txO MoewNYg> MmLu[I9{\SCmZYDlcoRmdnSueTDzeZBxemW|c3XzJHNRUC2rbnT1Z4VlKFCjcj20JINt\WG4YXflMEBRSVKSIHPs[YF3[WenLDDEUmEh\nKjZ33lcpRifGmxbjygZY5lKGyxc4Ogc4YhfmmjYnnsbZR6 MV6yN|Q1Ojl5Nh?=
CNE-1 M1THUmFxd3C2b4Ppd{BCe3OjeR?= NF2wZoszOM7:TdMg NILGWnozPGh? MlnKbY5pcWKrdIOgVmFFODBzLXnu[JVk\WRiY3XscEBl\WG2aB?= NYLMNpZzOjN2Mk[4OVA>
HONE-1 M4HycmFxd3C2b4Ppd{BCe3OjeR?= M4L4WlIx|ryPwrC= MX6yOIg> Mnn2bY5pcWKrdIOgVmFFODBzLXnu[JVk\WRiY3XscEBl\WG2aB?= NILTVnkzOzR{Nki1NC=>
astrocytes cell NWe0e3I6SXCxcITvd4l{KEG|c3H5 NX;2XnBWPDEQvF2= NVP1WXJmPmh? MnS2doVlfWOnczDlZZJtgSCjcH;weI9{cXNiaX7keYNm\CCkeTDzeIF2em:|cH;ybY5m MkTMNlM1OTF5N{i=
U-937 MV7BdI9xfG:|aYOgRZN{[Xl? NGPRXYMyOM7:TR?= MXuzNI1qdg>? MUTwdoV3\W62czDUUmYucW6mdXPl[EBv\WO{b4D0c5Nqew>? MnzPNlM1OTB5NEi=
MDA-MB-231 NHzxUnRCeG:ydH;zbZMhSXO|YYm= MmL1NVAx|ryP NUnVfWd2OWh? NVmy[|RIcW6qaXLpeJMhe2Wwc3n0bZpifGmxbjD0c{BVWkGLTDD1dI9vKE2WRFig[I94di2{ZXf1cIF1cW:w NY[1eXRvOjN2MEi0Nlk>
HeLa  NWfTZZpVSXCxcITvd4l{KEG|c3H5 M335[FExOM7:TR?= M2H4NlJp MYLicI9kc3NiSmLTMVE2KEmwZIXj[ZMhSXCxcITveIlkKEOnbHygSIVifGh? NIfmdWwzOzN2NEC0OS=>
Ec109 NYfSSmdoSXCxcITvd4l{KEG|c3H5 NXHJUFRzOTEQvF2= M1j0OVZp NXSybmI2[myxY3vzJIFxd3C2b4TpZ{Bkd22kaX7heIlwdiCxZjDUZZQuW22jY163JIFv\CC{YXTpZZRqd25? M3r3WlI{OzN6NU[4
H460  Ml3LRZBweHSxc3nzJGF{e2G7 MkL4NVDPxE1? MUm2bC=> NVSzOIpn[myxY3vzJIFxd3C2b4TpZ{Bkd22kaX7heIlwdiCxZjDUZZQuW22jY163JIFv\CC{YXTpZZRqd25? M1[zZVI{OzN6NU[4
HeLa  MVrBdI9xfG:|aYOgRZN{[Xl? NVfXUGpjPTEQvF2= MUKxMlVp MknNZYJzd2ejdHXzxsBEcGyjbYnkbYEucW6mdXPl[EBieG:ydH;zbZM> MX:yN|MxOzhyNB?=
SK-HEP1 MYXBdI9xfG:|aYOgRZN{[Xl? M3H5R|ExOM7:TR?= MonRNYg> NW\U[HJrcW6qaXLpeJMhS3KWMTDhZ5RqfmG2ZXSgZ4F{eGG|ZT2zMEAuPyxiLUisJE06NCCjbnSgdI9tgSiDRGCtdoljd3OnKTDwc4x6dWW{YYPl NGHvNGwzOzNyMk[1NC=>
QGY7701 M121WmFxd3C2b4Ppd{BCe3OjeR?= NVTmT2NyOjYQvF2= MnHkNU42cA>? NIPFXVRqdmirYnn0d{Bi[2O3bYXsZZRqd25ib3[gd5VjNUdzIIDoZZNmKGmwZIXj[YQh[nliRF;YJEsheXWncnPleIlv MoLxNlMzPDByNkG=
HepG2 NIDoeVhCeG:ydH;zbZMhSXO|YYm= Mn;lNlDPxE1? MnL1N|BucW5? NGHVSXVqdmirYnn0d{B1cGViZX7oZY5k\WRiY3XscEBl\WG2aDDifUBkd22kaX7l[EB1emWjdH3lcpQhd2ZiYYDp[4VvcW5iYX7kJHRTSUmO NXLZSGVuOjN{MkSyN|k>
U87  MofkRZBweHSxc3nzJGF{e2G7 MYmyOe69VQ>? M1jnelJp M1PQNIRm[3KnYYPld{Bqe2:uaYH1bZJqfGmpZX7pckApUVOOKT3pcoR2[2WmIHHwc5B1d3SrYzDj[YxtKGSnYYToMEBjfXRibn;0JI5m[3KxdHnjJINmdGxiZHXheIg> NFfIT2UzOzJ{OU[yOi=>
HSC-2 Mo\jRZBweHSxc3nzJGF{e2G7 M17ye|I2NzVyzszN MWqxbC=> MWrpcohq[mm2czDTUk0{QC2rbnT1Z4VlKGO7dH;0c5hq[2m2eR?= NInUfmozOzF3NUK0PC=>
HSC-4 MXvBdI9xfG:|aYOgRZN{[Xl? MXWyOU82OM7:TR?= NU\jPWNNOWh? NXHRSGFIcW6qaXLpeJMhW05vM{itbY5lfWOnZDDjfZRwfG:6aXPpeJk> NXnwSmFqOjNzNUWyOFg>
CL-1 MUPBdI9xfG:|aYOgRZN{[Xl? MlzuNlDPxE1? M2XjVFFp MVzicI9kc3NiT2C0OFkhcW6mdXPl[EBk\WyuIHTlZZRp MXeyN|E{OTd6Mh?=
MEL MkfJRZBweHSxc3nzJGF{e2G7 MWOyNO69VQ>? M2PqZ|I1cA>? MkDmSG1UVw>? MljibY1x[Wm{ZYOgVFJZPy2rbnT1Z4VlKE2HTDDj[YxtKGGyb4D0c5Nqew>? NETwVnozOzBzNEi4Oy=>
Bel-7402  M1PWbmNie3Cjc3WgRYN1cX[jdHnvckBCe3OjeR?= M{nsWlUx|ryP NInnU|UzcA>? MXXpcohq[mm2czDQR2UucW6mdXPl[EBidm:ra3nz NIL5bYIzOzByOEe0Ni=>
Eca-109 M3LBdWFxd3C2b4Ppd{BCe3OjeR?= NF20NY8zPc7:TR?= MmXwN|BucW5? MmXubY5pcWKrdIOgRmouSjFzLXnu[JVk\WRiY3XscEBl\WG2aB?= MlPkNlMxPzZ7Nke=
MEL MWHBdI9xfG:|aYOgRZN{[Xl? M{SxPVIx|ryP NX7pPVFCOWh? MmXHSG1UVw>? MVvpcZBicXKnczDQNng4NWmwZIXj[YQhVUWOIHPlcIwh[XCxcITvd4l{ Mnu1NlMxOTR6OEe=
Bel-7402  NX24TXJrSXCxcITvd4l{KEG|c3H5 NH7KTpE2OM7:TR?= NGDmZZozcA>? NXHYWYZocW6qaXLpeJMhWEOHLXnu[JVk\WRiYX7vbYtqew>? NXXqTIc3OjNyMEi3OFI>
L929 MkKySpVv[3Srb36gRZN{[Xl? NIi0Xm0zNjYQvF2= MljSNYg> NHf4OFhqdmO{ZXHz[ZMhWkmSMTDlfJBz\XO|aX;uJIFv\CCneHHj[ZJj[XSnZDDUUmbPuS2rbnT1Z4VlKG2rdH;jbI9v\HKrYXyg[Jl{\nWwY4Tpc44h[W6mIGLPV{Bxem:mdXP0bY9v MknLNlMxODB3MUi=
RCC  NHvneplE\WyuIG\pZYJqdGm2eTDBd5NigQ>? MV2xNFDPxE1? MWmyOIg> NGLDe2tz\WOxdnXy[ZMhfGinII\pZYJqdGm2eTDv[kBk\WyuczDlfJBwe2WmIITvJFE2\C2SR1qy NHvxU2wzOjl7MUS5OC=>
NB2a/d1 MX;BdI9xfG:|aYOgRZN{[Xl? MYmxNFDPxE1? M1LpVlczcA>? NIfHN|FifHSnboXheIV{KHO2YYXyc5Nxd3KrbnWtbY5lfWOnZDDjZZNx[XOnIHHjeIl3cXS7LDDQRXJRNCCjbnSgeIF2KGOuZXH2ZYdm MoS4NlI6QDh3NEG=
T cell M2nYWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmfDNlUuOTByzszN NFflWWYzPGh? MkXW[I9{\S2mZYDlcoRmdnSueTDpcohq[mm2ZXSgWEBk\WyuIIDyc4xq\mW{YYTpc44hdWWmaXH0[YQhfGi{b4XnbEB1cGViY3:td5RqdXWuYYTpc44hf2m2aDDhcpRqNUOGMzDhcoQh[W62aT3DSFI5 MlvUNlI6QDJ3M{i=
K562 MXfBdI9xfG:|aYOgRZN{[Xl? NFq4dHEyODEQvF2= MVyxbC=> M3z6SIJtd2OtczDBZo5w[mG4aYPjeY3DqEZvaX7keYNm\CCjcH;weI9{cXN? MmrJNlI6PzJ|N{K=
Jurkat  NXHsNohuSXCxcITvd4l{KEG|c3H5 MX60NO69VQ>? M3S1b|Fp NEfrU|Bi[m:uaYPo[ZMhTmG|TD3pcoR2[2WmIHPhd5Bie2ViYXP0bZZifGmxbjDhcoQh[2WubDDk[YF1cA>? NVLGZ3RPOjJ7NEK3N|g>
BGC-823 M4LnbWFxd3C2b4Ppd{BCe3OjeR?= MWKxNFDPxE1? NIXlb2YycA>? MlP3dIFzfGmjbHz5JJJme2O3ZYOgZ4VtdHNiYXfhbY5{fCCmYX3h[4Uhd2ZiZHHp[JpmcW5? M3THO|IzQTJ4NUS1
Hep3B M3K4OGFxd3C2b4Ppd{BCe3OjeR?= MmnMOVDPxE1? NVLWeFhqOWh? Ml7MZoxw[2u|IHHwc5B1d3OrczDpcoR2[2WmIHL5JGhGT0O| M3HXdVIzQTJ|MUW0
LLC-PK1 M4rjUGFxd3C2b4Ppd{BCe3OjeR?= MlvKNlDPxE1? Ml;GNYg> NI\qSoJxemW4ZX70d{BkcXOybHH0bY4ucW6mdXPl[EBl\We{YXTheIlwdiCxZjDBeIc2NCCkZXPsbY4uOSxiYX7kJGF1\zF{IIDyc5RmcW6| NYe5co45OjJ6OU[wN|c>
A549 M4P4dmFxd3C2b4Ppd{BCe3OjeR?= MlTFOVDPxE1? NHvNTFYycA>? M1fXOoJtd2OtczD0bIUhSkGLLXnu[JVk\WRiYYDvdJRwe2m|wrC= Mnq0NlI5QDd{MUW=
SGC-7901  M1LoSWFxd3C2b4Ppd{BCe3OjeR?= MX2xNO69VQ>? NGj1V44zPGh? NYTMNXhEcW6qaXLpeJMh|rJuzsKt[Ilu\XSqeXzhZ5J6dHOqaXvvcolvNWmwZIXj[YQh[XCxcITvd4l{yqB? MUWyNlg1QDV7Nx?=
DM6 M2Xlc2Fxd3C2b4Ppd{BCe3OjeR?= MmPtNVAx|ryP MV23Nog> MlHjZoxw[2u|IHLveIghTTKILUGgZY5lKEV{RoTyMY1m\GmjdHXkJIN6fG:2b4jpZ4l1gQ>? MkH4NlI5OjV|Mki=
MCF-7, MDA-MB-468, Caco-2 NV\mfIhyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV:2b|JvPTEQvF2= MW[0PIg> NYPMfJpEcW6qaXLpeJMhfGinIHPlcIwh\3Kxd4ToJIlvcGmkaYTpc44hcW6mdXPl[EBjgSC|YYDvcolv MYGyNlgxODl4OB?=
A2750  MYPBdI9xfG:|aYOgRZN{[Xl? NXn3OJFWOjEQvF2= MnvFNog> MYnEUXNQ NFuyeXpjdG:la4OgZ4F{eGG|ZTDjcIVifmGpZTDkeZJqdmdiaHXs[Y5idGmwIITy[YF1dWWwdDDhcoQhemWmdXPld{BifXSxcHjh[4lkKGOnbHyg[IVifGh? NUfUSXJQOjJ5OESzOlM>
U87  M4H1SGFxd3C2b4Ppd{BCe3OjeR?= MkjwNlDPxE1? NVrPbWtZOjSq NWfOO5M{emWmdXPld{B1cGViYYDvdJRwe2m|IILheIUhcW6mdXPl[EBjgSCSTFHC M1LpZ|IzPzd6N{iw
HT1080 MkSwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYm1NO69VQ>? M3PXfVdl M{TlNIlvcGmkaYTzJJRp\SClZXzsJIdzd3e2aDDpcohq[mm2aX;uJINifXOnZDDifUBkd22kaX7l[EB1emWjdH3lcpQhd2ZiRFPBJIFv\CCRTWC= MWqyNlc1ODl6NB?=
A549  MnvkRZBweHSxc3nzJGF{e2G7 NVrS[3pkPTEQvF2= NX;Z[FhkOmh? MX3wZZJ1cWGubImg[IVkemWjc3XzJJNw\Gm3bTDz[Yxmdmm2ZT3pcoR2[2WmIHHwc5B1d3Orcx?= MkKzNlI4OjF6MES=
Primary OPC NYTtTIk3SXCxcITvd4l{KEG|c3H5 M4PtSVHPxE1? MYe2bE8zPGh? MlHudoVlfWOnczD0bIUheGW{Y3XueIFo\SCxZjDj[YxteyCrbjDlZZJtgS1iYX7kJIxifGVvYYDvdJRwe2m|L37lZ5Jwe2m| NHHiRZQzOjdyN{O4OS=>
PMNs MUTBdI9xfG:|aYOgRZN{[Xl? Mkm5OFDPxE1? NHy5WYE3cA>? NHj0e3dFVVOR MmLsdoV3\XK|ZXSgeIhmKGGvb4XueEBw\iClbHXheoVlKGOjc4Dhd4UuOyC2bzDu[YFzKH[naHnjcIUhdGW4ZXzz M3yyXVIzPjl{NUe3
A549  MmPTRZBweHSxc3nzJGF{e2G7 MmD5OVDPxE1? NYnVNIN{OWh? NH7DdnNxemW4ZX70d{BieG:ydH;zbZMhcW6mdXPl[EBjgSCEYX;oeY9{cWSnIFm= NWryVIZOOjJ4OEe2N|U>
AGS NFXPW5NCeG:ydH;zbZMhSXO|YYm= MX[yNO69VQ>? M4ezUlEzcA>? M1y4XYlvcGmkaYTzJJRp\SCjY4TpeoF1cW:wIH;mJJBzdy2lYYPwZZNmNTNiaX6gdoV{eG:wc3WgeI8hfGinIFX0U2FkKG[{YXP0bY9v MV2yNlY5PzN7OB?=
shC9  NUXHVYJ2SXCxcITvd4l{KEG|c3H5 NH3ab|AyOM7:TR?= MknQNVZp M13aR4JtfW62czDTTGgh\XiycnXzd4lwdiCrbjDzbGM6KGOnbHzzJIV5eG:|ZXSgeI8h\Wm2aHXyJHBCKG:{IFzQRy=> MnroNlI3PDFyOUS=
primary MEFs NHrINJFHfW6ldHnvckBCe3OjeR?= M2fyb|EzcA>? MVZCpIlv[3KnYYPld{BmfG:yb4Pp[IUucW6mdXPl[EBucXSxY3jvcoRzcWGuIH3lcYJz[W6nIHTldI9t[XKrenH0bY9v MWWyNlYyOzd4Nx?=
3T9 MEFs Mk\5SpVv[3Srb36gRZN{[Xl? NHTIeI8yPmh? MYXpcoNz\WG|ZYOgZ5l1d2Oqcn;t[UBkKHKnbHXhd4Uh[W[2ZYKg[ZRweG:|aXTlMZRz\WG2bXXueC=> M13iVFIzPjF|N{[3
3T9 MEFs NVXNTI5KTnWwY4Tpc44hSXO|YYm= MkfkNVhp NVvQbXI2fXC{ZXf1cIF1\XNiaX7peIlifG:{IHPhd5Bie2VvOTDieZQh\G:5boLl[5Vt[XSnczDl[oZm[3SxcjDjZZNx[XOnczDh[pRmeiCndH;wc5Nq\GVidILlZZRu\W62 MVuyNlYyOzd4Nx?=
MDA-MB-231  NE\UXWlCeG:ydH;zbZMhSXO|YYm= NGrHTHEzOM7:TR?= NITOe|E1\A>? NVXicFZ{emWmdXPld{B1cGViY3XscEBieG:ydH;zbZMhcW6mdXPl[EBjgSCvZYTmc5JucW5idILlZZRu\W62IIfhd{B{cWewaX\pZ4FvfGy7 NVz3R|NFOjJ3OUO0OFE>
C6  NFi3VW1CeG:ydH;zbZMhSXO|YYm= MWOxNO69VQ>? Mn32NlRp NFqze2xjdG:la4OgeIhmKHO3cIDy[ZN{cX[nIHXm[oVkfCCxZjD0bIUheGWydHnk[UBwdiC4aXHibYxqfHl? MoHGNlI2QDh7OEC=
HL-60  NGjWeolCeG:ydH;zbZMhSXO|YYm= M{P5R|ExOM7:TR?= M4rZ[|I1cA>? MnnlbY5pcWKrdIOgeIhmKGOnbHygZZBweHSxc3nzJJNmdGWldHXkJEgsMS2vZX70bJltKM7{LTix5qaTPilvZHnncJVkd3C7cnHuc5Nq\GYEoEW= M{L5eVIzPTR4Nk[5
HL-60 M2fFSWFxd3C2b4Ppd{BCe3OjeR?= M2DCWlExNThyzszN MlntOIg> M3P0eIlvcGmkaYTzJHRIUFFvaX7keYNm\CClZXzsJIFxd3C2b4Ppd:Kh M{fONVIzPTJ|MkK5
BCC M4j0TWFxd3C2b4Ppd{BCe3OjeR?= NIf3fYE2OM7:TR?= MX6xbC=> MnrabY5pcWKrdIOgSGFVWy2vZXTpZZRm\CCpcn;3eIghcW6qaXLpeIlwdg>? NHzrW3czOjVzOUSzOi=>
RAW 264.7 M3jxUGFxd3C2b4Ppd{BCe3OjeR?= M2q4clUxNzFyMN88US=> MXixbC=> MX7jc45k\W62cnH0bY9vNWSncHXu[IVvfCCrbnjpZol1eyCGT16tbY5lfWOnZDDyVm5CKGOuZXH2ZYdm MmLWNlI1QTF2Mk[=
K562 MWXBdI9xfG:|aYOgRZN{[Xl? NFnJd3UzPc7:TR?= M{TuUlJp NEnxV3ZxemW4ZX70d{BieG:ydH;zbZMhcW6mdXPl[EBjgSClbz30doVifG2nboSge4l1cCCjbYXy[Y5{cW5iRzDhcoQhXFKDSVy= M3m2R|IzPDh|N{e3
SGC-7901 M1TNcGFxd3C2b4Ppd{BCe3OjeR?= NHi0NGEzOCEQvF5CpC=> M1foXVJp MVXheJRmdnWjdHXzJGgzVzMEoH;yJHRPTiEQsT3pcoR2[2WmIHPlcIwh[XCxcITvd4l{KGG|IIflcIwh[XNiY3HzdIF{\S1|IHHjeIl3cXS7wrC= NVv2T3QxOjJ2N{G1PFk>
PC3 MYDBdI9xfG:|aYOgRZN{[Xl? M2jVTlEx|ryP M13mUFRp NGPpcZZkd3WwdHXyd{BndGG4b3PvfIllNWmwZIXj[YQh[2G|cHHz[U1z\WyjdHXkJIFxd3C2b4Ppdy=> MX[yNlQ4OTl5NB?=
SMMC-7721 M1jNUGFxd3C2b4Ppd{BCe3OjeR?= NUTZb5lvPTEQvF2= M2jiXVQ5cA>? M4PsZYF1fGWwdXH0[ZMhd1SULXnu[JVk\WRiYYDvdJRwe2m| MWiyNlQ3PTh|Mx?=
HeLa  M3Tke2Fxd3C2b4Ppd{BCe3OjeR?= MUO1NOKh|ryP M{j0T|QwQGh? NUfBRW95cW6qaXLpeJMhW1SVLXnu[JVk\WRibHH0[U1xcGG|ZTDhdI9xfG:2aXOg[ZZmdnS| NU\iTol[OjJ2NkC1NFQ>
HeLa  NH3CUY9CeG:ydH;zbZMhSXO|YYm= MlvXOVDDqM7:TR?= MXixbC=> NUjkdGZKe3WycILld5NmeyC2aHWgSnJCWC2rbnT1Z4VlKGGlY4XteYxifGmxbjDv[kBidm6neHnuJHYheG:|aYTpeoUh[2WubIO= MnnwNlI1PDl2NEC=
T47D  NITET2hCeG:ydH;zbZMhSXO|YYm= MUixNFDPxE1? MonqNYg> NFXOd3VjdG:la4OgeIhmKGenbnXyZZRqd25ib3[gSU1k[WRxQ2TGNkBjgSCVVGO= NXjwWXdNOjJ2MEGxOlg>
HeLa  NIXRNpRCeG:ydH;zbZMhSXO|YYm= Mle1N|DPxE1? M4PDPVRp NXjmd|N6yqCrbnPy[YF{\XNidHjlJIdmdmW{YXygZ4VtdCC4aXHibYxqfHliNEigbEBi\nSncjDwbI91d2S7bnHtbYMhfHKnYYTt[Y51yqB? MYCyNlM6PDJ2OB?=
HCC MnT5RZBweHSxc3nzJGF{e2G7 NYPne2dIOjBizszNxsA> MlTNNog> NFfDcnJifHSnboXheIV{KHSqZTDETGEhcW6mdXPl[EBi[3SrdnH0bY9vKG:oIGDBVnA> M2PBZ|IzOzR{N{Oy
mESCs M4n1ZWFxd3C2b4Ppd{BCe3OjeR?= NYn2Z4I5Oi53zszN M1\tNFJp MnPlbY5pcWKrdIOgeIhmKE6jRj3t[YRq[XSnZDDjZZNx[XOnIHHjeIl3[XSrb36= NHLkeWwzOjJ6NUK3OC=>
EMT-6  NWOwWHh4S3m2b4TvfIlkcXS7IFHzd4F6 MWGxNFDPxE1? MkfBNYg> Ml75dIFzfGmjbHz5JIJtd2OtZXSgZ4VtdCCmZXH0bEBqdmS3Y3XkJIJ6KHOrcnHt[ZNqdmV? MUWyNlI2OTl{MR?=
MCF7 NXXqfo1USXCxcITvd4l{KEG|c3H5 Mof4OVDDqM7:TR?= NUHvWIFSOWh? NXznd2FmcW6qaXLpeJMhWEFiYXP0bZZifGWmIHPhd5Bie2VvMzygMVktKGGwZDDwc4x6MEGGUD3ybYJwe2VrIIDvcJlu\XKjc3W= M1mwdlIzOjJ|M{S1
K562 MX\BdI9xfG:|aYOgRZN{[Xl? MojxNlAh|ryPwrC= MmfROFhp M1LEOGROW09? MXjicI9kc3NibHHwZZRqdmmkLXnu[JVk\WRiaX7obYJqfGmxbjDv[kB3cWGkaXzpeJkh[W6mIHHwc5B1d3OrczDpcoR2[3Srb36= M2DyRVIzOjF4MUW4
Molt4-hyg M3P1O2Fxd3C2b4Ppd{BCe3OjeR?= M1XO[VEx|ryP NHn4WnUxNjWq M3Lje4Jtd2OtczDmZZJv\XOxbD3pcoR2[2WmIHPhd5Bie2VvMz3sbYtmKGGldHn2bZR6 NVjBb4l1OjZ{N{W4NVE>
HeLa Mn7mRZBweHSxc3nzJGF{e2G7 NFWyTXoyOM7:TR?= NXXzW5B{OC53aB?= MoXEbY5pcWKrdIOgZZBweHSxc3nzJIlv\HWlZXSgZpkhfGinIHPvcYJqdmWmIITy[YF1dWWwdDD3bZRpKGexbXnzbY4hViCjbnSgWHJCUUx? NFv6R5QzOjF5OU[2NS=>
Jurkat T NUS1UnZWSXCxcITvd4l{KEG|c3H5 NIfjTI8{OM7:TR?= NW\l[GluOC53aB?= NGjSXFdFVVOR NWLIZmpi[myxY3vzJJRp\SC8aYLhcU1qdmS3Y3XkJIFxd3C2b4Ppdy=> Ml\iNlIyPTl6OUi=
Neutrophil MnP6RZBweHSxc3nzJGF{e2G7 NFPuO4QzOM7:TR?= NYnz[XFSOC53aB?= M4XSPYF1fGWwdXH0[ZMhfGinIIDyc{1ieG:ydH;0bYMh\W[oZXP0JI9nKE2jUkG= MVWyOlE6Pjh2NB?=
HCT116 M1SzZ2Fxd3C2b4Ppd{BCe3OjeR?= NV73XIxYPTEEoN88US=> MYWybC=> MU\y[ZZmenOnczDzfY5memerc4TpZ{BieG:ydH;zbZMh\W[oZXP0d{Bw\iClZXzlZ495cWJiYX7kJG5RSy1zNtMg MYOyNlE2QTd3Mh?=
MDA-MB-231  NEjpdoZCeG:ydH;zbZMhSXO|YYm= MmHlNk42NTdwNd88US=> MVeybC=> NX7tV4Q1cW6qaXLpeJMhfGinIHPlcIwh\GWjdHigc4YhVUSDLV3CMVI{OSClZXzsd{BqdmS3Y3XkJIJ6KFOGVDDpckBiKGOxbnPlcpRz[XSrb36g[IVx\W6mZX70JI1idm6nch?= MY[yNlEyPTV{Nh?=
LNCaP NVv3VYx{SXCxcITvd4l{KEG|c3H5 NF;YdIE1OM7:TR?= NWH1cHJtOmh? MYDpcohq[mm2czDieZRmcW5iaX7keYNm\CClZXzsJIFxd3C2b4Ppdy=> M3iwUlIzOTF2N{[0
MB231 NHrBbJdCeG:ydH;zbZMhSXO|YYm= MWKxNFDPxE1? NFvyeokycA>? NF35[m5FVVOR M3y2UYFjem:pYYTld{B1cGViaX7keYN1cW:wIH;mJINmdGxiZHXheIgh[nliV1XFNUBqdmirYnn0bY9vNCCWUlHJUEB1emWjdH3lcpQtKGGwZDD0bIUh[2:vYnnuZZRqd25? MmjkNlIyOTJ7NEC=
HCC38  NF;3Ro1CeG:ydH;zbZMhSXO|YYm= NGTZTW4yODEQvF2= NGLsUlkycA>? MYfEUXNQ M2rMXIFjem:pYYTld{B1cGViaX7keYN1cW:wIH;mJINmdGxiZHXheIgh[nliV1XFNUBqdmirYnn0bY9vNCCWUlHJUEB1emWjdH3lcpQtKGGwZDD0bIUh[2:vYnnuZZRqd25? NFy2NmgzOjFzMkm0NC=>
MDA-MB231 NUTw[JloSXCxcITvd4l{KEG|c3H5 NXPLd25[PTEEoN88US=> Mk\iNlRp MnTwSG1UVw>? NWDvOGg1[WK{b3fheIV{KGO3cnP1cYlvNWmwZIXj[YQh[2WubDDk[YF1cA>? NEj5R5EzOjFyMUOzOS=>
LNCaP MoH3RZBweHSxc3nzJGF{e2G7 M1HPWFUxyqEQvF2= MojnNlRp NF\BRlhFVVOR M2O0SYFjem:pYYTld{BkfXKldX3pck1qdmS3Y3XkJINmdGxiZHXheIg> M2rOdFIzOTBzM{O1
HCT116 MYTBdI9xfG:|aYOgRZN{[Xl? MkX2OVDDqM7:TR?= M4DEblI1cA>? MUHEUXNQ NWX3ZW93[WK{b3fheIV{KGO3cnP1cYlvNWmwZIXj[YQh[2WubDDk[YF1cA>? M3m2Z|IzOTBzM{O1
Ishikawa  MkLXRZBweHSxc3nzJGF{e2G7 MkLSNlXPxE1? NUjMZZMyOjSq NXXxdnZUemWmdXPld{Bk\WyuIHTlZZRpKGGwZDDhdI9xfG:|aYOgbY5lfWOnZDDifUBD[WZiQUG= M2OzR|IzODh6OUG4
 YD-8  MV7BdI9xfG:|aYOgRZN{[Xl? MWexNFDPxE1? NUjlUHQ4OWh? MYjpcohq[mm2czDQUGVQNWmwZIXj[YQh[XCxcITvd4l{ M3e2cFIzODh4MUiz
eosinophil  M1XSVWFxd3C2b4Ppd{BCe3OjeR?= M33xXlkx|ryP NX64eXc3OjSq M4fJe4lvcGmkaYTzJIFxd3C2b4Ppd{BqdmS3Y3XkJIJ6KE[jczDhcpRq[m:medMg MV:yNlA4QTN|NB?=
L929 M3HqOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3PXUVIvPc7:TR?= M3y3U|I1cA>? NIDvdZpqdmirYnn0d{B1cGViZYjwdoV{e2mxbjDv[kBxNXB|ODDhcoQhVkZvzsrCJJRwKGG3Z33lcpQhXE6IzsGtbY5lfWOnZDDu[YNzd3C2b4Ppd{BidmRiYYX0c5Bp[We7 MXuyNlAzPzB7Nx?=
YD-8  M1v2dmFxd3C2b4Ppd{BCe3OjeR?= NXyyWVBmOTByzszN MmHiNYg> MoLEZoxw[2u|IITo[UBIWy2KQ3ytbY5lfWOnZDDhdI9xfG:|aYO= NHPPPXkzOjB{MEC3PC=>
HBx NIrCfplCeG:ydH;zbZMhSXO|YYm= M1PuTlI2|ryP M{W3UlQ5cA>? NEKyVlBFVVOR MWPy[YR2[2WmIHPlcIwh\GWjdHigbY5lfWOnZDDifUA{NU2D NVzJRZBOOjJyMkCwO|g>
U937  NUDiSGR1SXCxcITvd4l{KEG|c3H5 MYW1NOKh|ryP MVWxbC=> NID1N2dqdmirYnn0d{BJTi2rbnT1Z4VlKGGyb4D0c5Nqe8Li MV[yNVk6QDd|MR?=
HL60 NX21[G1xSXCxcITvd4l{KEG|c3H5 NVy0eph{PDEQvF2= M2[wU|QxdWmw NUS3e5E4TE2VTx?= M4LsZ4Jtd2OtczDCUmREKGOxbYDveY5leyCrbnT1Z4Uh\Xiyb4P1doUhd2ZicHjvd5Bp[XSrZInsd4VzcW6nIHHu[EBFVkFiZoLh[41mdnSjdHnvci=> NH7qO|EzOTl6M{K5Oi=>
M-14 MY\BdI9xfG:|aYOgRZN{[Xl? MmTZNlXPxE1? MnyyNE42cA>? MXJCpIlvcGmkaYTzJIJwfGhidHjlJINzfWSnIHX4eJJi[3RvIHHu[EBkd22yb4Xu[E1qdmS3Y3XkJIFxd3C2b4Ppdy=> NEPOdmUzOTl3NEm1PS=>
SK-BR-3 M33sNGFxd3C2b4Ppd{BCe3OjeR?= MVe1NOKh|ryP MnPyNog> M4PZZoJtd2OtczDhdI9xfG:2aXOgSG5CKG[{YXft[Y51[XSrb36gbY5lfWOnZDDifUBkd22kaX7heIlwdiCxZjDTUU0yPjRiYX7kJJJi\GmjdHnvci=> MljFNlE6ODF|OE[=
MDA-MB-468 NUDJd4pnSXCxcITvd4l{KEG|c3H5 MnvNOVDDqM7:TR?= Mn;INog> M2fBUYJtd2OtczDhdI9xfG:2aXOgSG5CKG[{YXft[Y51[XSrb36gbY5lfWOnZDDifUBkd22kaX7heIlwdiCxZjDTUU0yPjRiYX7kJJJi\GmjdHnvci=> MYCyNVkxOTN6Nh?=

... Click to View More Cell Line Experimental Data

Protocol

Solubility (25°C)

Chemical Information

Molecular Weight 467.49
Formula

C22H30FN3O7

CAS No. 187389-52-2
Storage powder
in solvent
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Caspase Signaling Pathway Map

Related Caspase Products

Tags: buy Z-VAD-FMK | Z-VAD-FMK supplier | purchase Z-VAD-FMK | Z-VAD-FMK cost | Z-VAD-FMK manufacturer | order Z-VAD-FMK | Z-VAD-FMK distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID